These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30715822)

  • 1. lenalidomide (REVLIMID°) in untreated multiple myeloma.
    Prescrire Int; 2016 Nov; 25(176):263-264. PubMed ID: 30715822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multiple myeloma: an emphasis on new developments.
    Kyle RA; Vincent Rajkumar S
    Ann Med; 2006; 38(2):111-5. PubMed ID: 16581696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide: a review of its continuous use in patients with newly diagnosed multiple myeloma not eligible for stem-cell transplantation.
    McCormack PL
    Drugs Aging; 2015 May; 32(5):409-18. PubMed ID: 25925941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
    Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
    Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma.
    Dimopoulos MA; Cheung MC; Roussel M; Liu T; Gamberi B; Kolb B; Derigs HG; Eom H; Belhadj K; Lenain P; Van der Jagt R; Rigaudeau S; Dib M; Hall R; Jardel H; Jaccard A; Tosikyan A; Karlin L; Bensinger W; Schots R; Leupin N; Chen G; Marek J; Ervin-Haynes A; Facon T
    Haematologica; 2016 Mar; 101(3):363-70. PubMed ID: 26659916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematology: Is thalidomide combination a new option for myeloma?
    Palumbo A
    Nat Rev Clin Oncol; 2010 Aug; 7(8):425-6. PubMed ID: 20668477
    [No Abstract]   [Full Text] [Related]  

  • 7. A combination of melphalan, prednisone, and 50 mg thalidomide treatment in non-transplant-candidate patients with newly diagnosed multiple myeloma.
    Chang HJ; Lee JH; Do YR; Bae SH; Lee JL; Nam SH; Yoon SS; Bang SM
    Korean J Intern Med; 2011 Dec; 26(4):403-9. PubMed ID: 22205840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma.
    Ludwig H; Strasser-Weippl K; Schreder M; Zojer N
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix64-70. PubMed ID: 17631598
    [No Abstract]   [Full Text] [Related]  

  • 9. When less is more: results Herald 'paradigm shift' in treating newly diagnosed multiple myeloma patients.
    Caffrey MK
    Am J Manag Care; 2014 Feb; 20(2 Spec No.):E13. PubMed ID: 25764578
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolving role of novel agents for maintenance therapy in myeloma.
    Magarotto V; Palumbo A
    Cancer J; 2009; 15(6):494-501. PubMed ID: 20010169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
    Benboubker L; Dimopoulos MA; Dispenzieri A; Catalano J; Belch AR; Cavo M; Pinto A; Weisel K; Ludwig H; Bahlis N; Banos A; Tiab M; Delforge M; Cavenagh J; Geraldes C; Lee JJ; Chen C; Oriol A; de la Rubia J; Qiu L; White DJ; Binder D; Anderson K; Fermand JP; Moreau P; Attal M; Knight R; Chen G; Van Oostendorp J; Jacques C; Ervin-Haynes A; Avet-Loiseau H; Hulin C; Facon T;
    N Engl J Med; 2014 Sep; 371(10):906-17. PubMed ID: 25184863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy.
    Scott GB; Carter C; Parrish C; Wood PM; Cook G
    Cell Immunol; 2015 Sep; 297(1):1-9. PubMed ID: 26051632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.
    Dimopoulos MA; Chen C; Spencer A; Niesvizky R; Attal M; Stadtmauer EA; Petrucci MT; Yu Z; Olesnyckyj M; Zeldis JB; Knight RD; Weber DM
    Leukemia; 2009 Nov; 23(11):2147-52. PubMed ID: 19626046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trials investigate first-line thalidomide in multiple myeloma.
    Owen OG
    Lancet Oncol; 2005 Jan; 6(1):6. PubMed ID: 15672486
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of central nervous system myeloma manifesting as cauda equina nodules with intrathecal chemotherapy, lenalidomide and dexamethasone.
    Koo RM; Crispin P; Craft M; Lalloo S
    BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide: new drug. Myeloma: many questions remain unanswered.
    Prescrire Int; 2008 Dec; 17(98):230-2. PubMed ID: 19422142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How lenalidomide is changing the treatment of patients with multiple myeloma.
    Dimopoulos MA; Terpos E; Niesvizky R
    Crit Rev Oncol Hematol; 2013 Oct; 88 Suppl 1():S23-35. PubMed ID: 23816163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of lenalidomide in the treatment of multiple myeloma].
    Holánek M; Hájek R
    Klin Onkol; 2010; 23(2):67-72. PubMed ID: 20465083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma in the United States of America: A population-based cohort study.
    Luo J; Gagne JJ; Landon J; Avorn J; Kesselheim AS
    Eur J Cancer; 2017 Jan; 70():22-33. PubMed ID: 27866096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in oral therapy in the treatment of multiple myeloma.
    Doss DS
    Clin J Oncol Nurs; 2006 Aug; 10(4):514-20. PubMed ID: 16927905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.